Nadph oxidase 1 in liver macrophages promotes inflammation and tumor development in mice
Open accessAbstract
Background & Aims Although there are associations among oxidative stress, reduced nicotinamide adenine dinucleotide phosphate oxidase (NOX) activation, and hepatocellular carcinoma (HCC) development, it is not clear how NOX contributes to hepatocarcinogenesis. We studied the functions of different NOX proteins in mice after administration of a liver carcinogen. Methods Fourteen-day-old Nox1 –/– mice, Nox4 –/– mice, Nox1 –/– Nox4 –/– (double-knockout) mice, and wild-type (WT) C57BL/6 mice were given a single intraperitoneal injection of diethylnitrosamine (DEN) and liver tumors were examined at 9 months. We also studied the effects of DEN in mice with disruption of Nox1 specifically in hepatocytes ( Nox1 ΔHep ), hepatic stellate cells ( Nox1 ΔHep ), or macrophages ( Nox1 ΔMac ). Some mice were also given injections of the NOX1-specific inhibitor ML171. To study the acute effects of DEN, 8–12-week-old mice were given a single intraperitoneal injection, and liver and serum were collected at 72 hours. Liver tissues were analyzed by histologic examination, quantitative polymerase chain reaction, and immunoblots. Hepatocytes and macrophages were isolated from WT and knockout mice and analyzed by immunoblots. Results Nox4 –/– mice and WT mice developed liver tumors within 9 months after administration of DEN, whereas Nox1 –/– mice developed 80% fewer tumors, which were 50% smaller than those of WT mice. Nox1 ΔHep and Nox1 ΔHSC mice developed liver tumors of the same number and size as WT mice, whereas Nox1 ΔMac developed fewer and smaller tumors, similar to Nox1 –/– mice. After DEN injection, levels of tumor necrosis factor, interleukin 6 (IL6), and phosphorylated signal transducer and activator of transcription 3 were increased in livers from WT, but not Nox1 –/– or Nox1 ΔMac , mice. Conditioned medium from necrotic hepatocytes induced expression of NOX1 in cultured macrophages, followed by expression of tumor necrosis factor, IL6, and other inflammatory cytokines; this medium did not induce expression of IL6 or cytokines in Nox1 ΔMac macrophages. WT mice given DEN followed by ML171 developed fewer and smaller liver tumors than mice given DEN followed by vehicle. Conclusions In mice given injections of a liver carcinogen (DEN), expression of NOX1 by macrophages promotes hepatic tumorigenesis by inducing the production of inflammatory cytokines. We propose that upon liver injury, damage-associated molecular patterns released from dying hepatocytes activate liver macrophages to produce cytokines that promote tumor development. Strategies to block NOX1 or these cytokines might be developed to slow hepatocellular carcinoma progression.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Recognition of DAMPs released from damaged hepatocytes increases total cellular ROS levels and induces ERK1/2-mediated expression of IL-6 and TNF in BMDM.
“Mechanistically, recognition of damage-associated molecular patterns (DAMP) released from damaged hepatocytes in vitro increased total cellular ROS levels (see also Section 5.1) and induced extracellular signal-regulated kinases 1/2 (ERK1/2)-mediated expression of IL-6 and TNF in BMDM.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [319]
Liver macrophages, identified via cell-type specific Nox1 deletion, promote a proinflammatory liver environment, hepatocyte proliferation, tumor development, and liver damage, while Nox1 deletion in hepatocytes and bile duct cells has no effect.
“Liver macrophages were identified via cell-type specific Nox1 deletion as promoters of a proinflammatory liver environment, hepatocyte proliferation, tumor development and liver damage, while Nox1 deletion in hepatocytes and bile duct cells had no effect.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [319]
Nox1-deficient BMDM show no ROS production and no expression of cytokines.
“Nox1-deficient BMDM showed no ROS production and no expression of cytokines, nicely corroborating the in vivo findings.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [319]
Nox1-deficient, but not Nox4-deficient, animals show strongly reduced tumor numbers and size and reduced liver damage in a hepatocellular carcinoma model.
“Nox1-deficient, but not Nox4-deficient, animals showed strongly reduced tumor numbers and size and reduced liver damage.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [319]
Nox1/Nox4 double-deficient mice resemble Nox1-deficient mice, excluding an interconnection between the two Nox enzymes.
“Nox1/Nox4 double-deficient mice resembled Nox1-deficient mice excluding an interconnection between the two Nox enzymes.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [319]
In Nox1-deficient animals after chemically induced liver damage, total ROS levels in tumor tissue, tumor cell proliferation, and hepatic levels of IL-6 and TNF are reduced.
“Total ROS levels in tumor tissue, tumor cell proliferation and hepatic levels of the proinflammatory cytokines IL-6 and TNF were reduced after chemically induced liver damage in Nox1-deficient animals.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [319]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · see citing works
Self-citationThe NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · see citing works
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · see citing works
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · see citing works
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125 · see citing works
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065 · see citing works
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907 · see citing works
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679 · see citing works
Self-citationGender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955 · see citing works
Self-citationPark, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · see citing works
Self-citationMederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443 · see citing works
NF-κB and STAT3 – key players in liver inflammation and cancer
He, G., & Karin, M. (2010) · Cell Research · doi:10.1038/cr.2010.183 · Cited by 1,197 · see citing works
Self-citationHirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,187 · see citing works
Maeda, S., Kamata, H., Luo, J., Leffert, H. L., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,165 · see citing works
Self-citationIellem, A., Mariani, M., Lang, R., Recalde, H. R., Panina‐Bordignon, P., Sinigaglia, F., & D’Ambrosio, D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.847 · Cited by 915 · see citing works
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome
Afonina, I. S., Zhong, Z., Karin, M., & Beyaert, R. (2017) · Nature Immunology · doi:10.1038/ni.3772 · Cited by 772 · see citing works
Self-citationReparative inflammation takes charge of tissue regeneration
Karin, M., & Clevers, H. (2016) · Nature · doi:10.1038/nature17039 · Cited by 767 · see citing works
Self-citationUbiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J., Factor, V. M., & Thorgeirsson, S. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.006 · Cited by 710 · see citing works
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Llovet, J. M., Villanueva, A., Lachenmayer, A., & Finn, R. S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.103 · Cited by 619 · see citing works
Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment
Zhong, Z., Sánchez‐López, E., & Karin, M. (2016) · Cell · doi:10.1016/j.cell.2016.05.051 · Cited by 574 · see citing works
Self-citationWelzel, T. M., Graubard, B. I., Zeuzem, S., El‐Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 539 · see citing works
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521 · see citing works
Obesity, inflammation, and liver cancer
Sun, B., & Karin, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.020 · Cited by 496 · see citing works
Self-citationNADPH oxidase–derived free radicals are key oxidants in alcohol-induced liver disease
Kono, H., Rusyn, I., Yin, M., Gäbele, E., Yamashina, S., Dikalova, A., Kadiiska, M. B., Connor, H. D., Mason, R. P., Segal, B. H., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9020 · Cited by 493 · see citing works
STAT3 as a target for inducing apoptosis in solid and hematological tumors
Siddiquee, K., & Turkson, J. (2008) · Cell Research · doi:10.1038/cr.2008.18 · Cited by 488 · see citing works
He, G., Dhar, D., Nakagawa, H., Font-Burgada, J., Ogata, H., Jiang, Y., Shalapour, S., Seki, E., Yost, S. E., Jepsen, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.031 · Cited by 474 · see citing works
Self-citationHe, G., Yu, G.-Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., Sieghart, W., Peck-Radosavljevic, M., Leffert, H. L., & Karin, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.048 · Cited by 427 · see citing works
Self-citationThe chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells.
Zingoni, A., Soto, H., Hedrick, J. A., Stoppacciaro, A., Storlazzi, C. T., Sinigaglia, F., D’Ambrosio, D., O’Garra, A., Robinson, D. S., Rocchi, M., et al. (1998) · PubMed · Cited by 395 · see citing works
Cutting Edge: The Chemokine Receptor CCR8 Is Preferentially Expressed in Th2 But Not Th1 Cells
Zingoni, A., Soto, H., Hedrick, J. A., Stoppacciaro, A., Storlazzi, C. T., Sinigaglia, F., D’Ambrosio, D., O’Garra, A., Robinson, D., Rocchi, M., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.547 · Cited by 357 · see citing works
Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
Bruno, S., Silini, E. M., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., et al. (1997) · Hepatology · doi:10.1002/hep.510250344 · Cited by 356 · see citing works
Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336 · see citing works
Self-citationDiethylnitrosamine (DEN)-induced carcinogenic liver injury in mice
Tolba, R., Kraus, T., Liedtke, C., Schwarz, M., & Weiskirchen, R. (2015) · Laboratory Animals · doi:10.1177/0023677215570086 · Cited by 313 · see citing works
STAT family of transcription factors in cytokine-mediated biological responses
Takeda, K., & Akira, S. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00005-8 · Cited by 310 · see citing works
Knight, B., Yeoh, G. C., Husk, K. L., Ly, T., Abraham, L. J., Yu, C., Rhim, J. A., & Fausto, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1809 · Cited by 299 · see citing works
Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair
Leoni, G., Alam, A. M., Neumann, P.-A., Lambeth, J. D., Cheng, G., McCoy, J. W., Hilgarth, R., Kundu, K., Murthy, N., Kusters, D. H. M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65831 · Cited by 297 · see citing works
Jiang, J. X., Chen, X., Serizawa, N., Szyndralewiez, C., Page, P., Schröder, K., Brandes, R. P., Devaraj, S., & Török, N. J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.007 · Cited by 251 · see citing works
Obesity and diabetes as a risk factor for hepatocellular carcinoma
Regimbeau, J. M., Colombat, M., Mognol, P., Durand, F., Abdalla, E. K., Degott, C., Degos, F., Farges, O., & Belghiti, J. (2004) · Liver Transplantation · doi:10.1002/lt.20033 · Cited by 227 · see citing works
Trichopoulos, D., Bamia, C., Λάγιου, Π., Fedirko, V., Trépo, E., Jenab, M., Pischon, T., Nöthlings, U., Overved, K., Tjønneland, A. M., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr395 · Cited by 226 · see citing works
Role of NADPH Oxidases in Liver Fibrosis
Paik, Y., Kim, J., Aoyama, T., Minicis, S. D., Bataller, R. A., & Brenner, D. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5619 · Cited by 221 · see citing works
Self-citationThe impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
Polesel, J., Zucchetto, A., Montella, M., Maso, L. D., Crispo, A., Vecchia, C. L., Serraino, D., Franceschi, S., & Talamini, R. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn565 · Cited by 210 · see citing works
Wong, V. W., Yu, J. Q., Cheng, A. S. L., Wong, G. L., Chan, H., Chu, E. S., Ng, E. K. O., Chan, F. K. L., Sung, J. J. �., & Chan, H. L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24281 · Cited by 208 · see citing works
Role of CYP2E1 in Diethylnitrosamine-Induced Hepatocarcinogenesis In vivo
Kang, J. S., Wanibuchi, H., Morimura, K., Gonzalez, F. J., & Fukushima, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1369 · Cited by 203 · see citing works
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
Liang, S., Kisseleva, T., & Brenner, D. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00017 · Cited by 197 · see citing works
Self-citationLan, T., Kisseleva, T., & Brenner, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129743 · Cited by 192 · see citing works
Self-citationGianni, D., Taulet, N., Zhang, H., DerMardirossian, C., Kister, J., Martinez, L., Roush, W. R., Brown, S. J., Bokoch, G. M., & Rosen, H. (2010) · ACS Chemical Biology · doi:10.1021/cb100219n · Cited by 192 · see citing works
de Mochel, N. S. R., Seronello, S., Wang, S. H., Ito, C., Zheng, J. X., Liang, J. T., Lambeth, D. J., & Choi, J. (2010) · Hepatology · doi:10.1002/hep.23671 · Cited by 183 · see citing works
Obesity-associated mechanisms of hepatocarcinogenesis
Karagozian, R., Derdák, Z., & Baffy, G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.01.011 · Cited by 172 · see citing works
Nakagawa, H., Maeda, S., Yoshida, H., Tateishi, R., Masuzaki, R., Ohki, T., Hayakawa, Y., Kinoshita, H., Yamakado, M., Kato, N., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24720 · Cited by 169 · see citing works
Bettaieb, A., Jiang, J. X., Sasaki, Y., Chao, T.-I., Kiss, Z., Chen, X., Tian, J., Katsuyama, M., Yabe-Nishimura, C., Xi, Y., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.009 · Cited by 167 · see citing works
Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Llovet, J. M., Villanueva, A., Lachenmayer, A., & Finn, R. S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.121 · Cited by 163 · see citing works
The human cytokine I-309 is a monocyte chemoattractant.
Miller, M. D., & Krangel, M. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2950 · Cited by 158 · see citing works
Bile Salt–Induced Apoptosis Involves NADPH Oxidase Isoform Activation
Reinehr, R., Becker, S., Keitel, V., Eberle, A., Grether‐Beck, S., & Häussinger, D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.023 · Cited by 149 · see citing works
Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPARα Mediated Mechanism
Garrido-Urbani, S., Jemelin, S., Deffert, C., Carnesecchi, S., Basset, O., Szyndralewiez, C., Heitz, F., Page, P., Montet, X., Michalik, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014665 · Cited by 143 · see citing works
Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma
Han, S., Bai, E., Jin, G., He, C., Guo, X.-J., Wang, L., Li, M., Xia, Y., & Zhu, Q. (2014) · Journal of Immunology Research · doi:10.1155/2014/261365 · Cited by 124 · see citing works
Cui, W., Matsuno, K., Iwata, K., Ibi, M., Matsumoto, M., Zhang, J., Zhu, K., Katsuyama, M., Torok, N. J., & Yabe‐Nishimura, C. (2011) · Hepatology · doi:10.1002/hep.24465 · Cited by 113 · see citing works
Mouse Liver Tumorigenesis: Models, Mechanisms, and Relevance to Human Disease
Fausto, N. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007114 · Cited by 110 · see citing works
Inflammation and liver tumorigenesis
Sun, B., & Karin, M. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0256-4 · Cited by 88 · see citing works
Self-citationRole and Cellular Source of Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Hepatic Fibrosis
Minicis, S. D., Seki, E., Paik, Y., Österreicher, C. H., Kodama, Y., Kluwe, J., Torozzi, L., Miyai, K. N., Benedetti, A., Schwabe, R. F., et al. (2010) · Hepatology · doi:10.1002/hep.23804 · Cited by 83 · see citing works
Self-citationTeufelhofer, O. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh320 · Cited by 78 · see citing works
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.
Ahmed, F., Perz, J. F., Kwong, S. L., Jamison, P. M., Friedman, C., & Bell, B. P. (2008) · PubMed Central · Cited by 77 · see citing works
NADPH Oxidases in Chronic Liver Diseases
Jiang, J. X., & Torok, N. J. (2014) · Advances in Hepatology · doi:10.1155/2014/742931 · Cited by 76 · see citing works
Li, C., Deng, M., Hu, J., Li, X., Chen, L., Ju, Y., Hao, J., & Meng, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7740 · Cited by 69 · see citing works
Self-citationSquiring immunotherapy to CheckMate
Hutchinson, L. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.110 · Cited by 63 · see citing works
Enríquez‐Cortina, C., Bello‐Monroy, O., Rosales-Cruz, P., Souza, V., Miranda, R. U., Toledo-Pérez, R., Luna‐López, A., Nieves, A. S., Hernández‐Pando, R., Gutiérrez‐Ruíz, M. C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22024 · Cited by 52 · see citing works
HMGB1 as a Potential Therapeutic Target
Wang, H., Li, W., Goldstein, R. S., Tracey, K. J., & Sama, A. E. (2006) · Novartis Foundation symposium · doi:10.1002/9780470059593.ch6 · Cited by 47 · see citing works
Ho, J. C.-Y., Cheung, S., Leung, K. L., Ng, I. O., & Fan, S. T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20282 · Cited by 44 · see citing works
García‐Ruíz, I., Solís‐Muñoz, P., Fernández-Moreira, D., Grau, M., Muñoz‐Yagüe, T., & Solis-Herruzo, J. A. (2016) · Scientific Reports · doi:10.1038/srep23664 · Cited by 36 · see citing works
Ha, S. Y., Paik, Y., Yang, J. W., Lee, M. J., Bae, H., & Park, C.-K. (2016) · Gut and Liver · doi:10.5009/gnl15543 · Cited by 31 · see citing works
Lu, C.-L., Qiu, J.-L., Huang, P., Zou, R.-H., Hong, J., Li, B., Chen, G.-H., & Yuan, Y. (2011) · Tumor Biology · doi:10.1007/s13277-011-0220-3 · Cited by 28 · see citing works
Hirose, Y., Naito, Z., Kato, S., Onda, M., & Sugisaki, Y. (2002) · Journal of Nippon Medical School · doi:10.1272/jnms.69.243 · Cited by 15 · see citing works
TLR4 induces CCR7-dependent monocytes transmigration through the blood–brain barrier
Paradis, A., Bernier, S., & Dumais, N. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.03.019 · Cited by 13 · see citing works
Flagged first, then by citations
1 of the 72 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
Targher, G., Byrne, C. D., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2023-330595 · Cited by 997 · see citing works
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Steven, S., Frenis, K., Oelze, M. W., Kalinovic, S., Kuntić, M., Jiménez, M. T. B., Vujačić-Mirski, K., Helmstädter, J., Kröller‐Schön, S., Münzel, T. F., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7092151 · Cited by 729 · see citing works
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633 · see citing works
Oxidative Stress in Liver Pathophysiology and Disease
Allameh, A., Niayesh‐Mehr, R., Aliarab, A., Sebastiani, G., & Pantopoulos, K. (2023) · Antioxidants · doi:10.3390/antiox12091653 · Cited by 565 · see citing works
Reactive Oxygen Species in Macrophages: Sources and Targets
Canton, M., Sánchez‐Rodríguez, R., Spera, I., Venegas, F. C., Favia, M., Viola, A., & Castegna, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.734229 · Cited by 463 · see citing works
Mechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 440 · see citing works
Self-citationBaglieri, J., Brenner, D. A., & Kisseleva, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071723 · Cited by 341 · see citing works
Self-citationLi, N., Guo, Y., Gong, Y., Zhang, Y., Fan, W., Yao, K., Chen, Z., Dou, B., Lin, X., Chen, B., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s341581 · Cited by 264 · see citing works
Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2022.11.013 · Cited by 262 · see citing works
Self-citationMa, H.-Y., Yamamoto, G., Xu, J., Liu, X., Karin, D., Kim, J. Y., Alexandrov, L. B., Koyama, Y., Nishio, T., Benner, C., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.016 · Cited by 216 · see citing works
Self-citationImmune cell - produced ROS and their impact on tumor growth and metastasis
Kennel, K. B., & Greten, F. R. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101891 · Cited by 209 · see citing works
Carcinogenesis: Failure of resolution of inflammation?
Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107670 · Cited by 207 · see citing works
Antioxidant Therapy in Cancer: Rationale and Progress
Luo, M., Zhou, L., Huang, Z., Li, B., Nice, E. C., Xu, J., & Huang, C. (2022) · Antioxidants · doi:10.3390/antiox11061128 · Cited by 201 · see citing works
Self-citationMacrophages and hepatocellular carcinoma
Tian, Z., Hou, X.-J., Liu, W.-T., Han, Z.-P., & Wei, L.-X. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0342-7 · Cited by 148 · see citing works
Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?
Wang, R., Liang, L., Matsumoto, M., Iwata, K., Umemura, A., & He, F. (2023) · Biomolecules · doi:10.3390/biom13020353 · Cited by 105 · see citing works
NADPH oxidases: redox regulation of cell homeostasis and disease
Kračun, D., Lopes, L. R., Cifuentes-Pagano, E., & Pagano, P. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00034.2023 · Cited by 104 · see citing works
Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
Lin, L., Gong, H., Li, R., Huang, J., Cai, M., Lan, T., Huang, W., Guo, Y., Zhou, Z., An, Y., et al. (2020) · Advanced Science · doi:10.1002/advs.201903138 · Cited by 101 · see citing works
Self-citationShinn, J., Park, S., Lee, S., Park, N., Kim, S., Hwang, S., Moon, J. J., Kwon, Y., & Lee, Y. (2024) · ACS Nano · doi:10.1021/acsnano.3c06107 · Cited by 101 · see citing works
The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH Oxidases
Gabbia, D., Cannella, L., & Martin, S. D. (2021) · Biomedicines · doi:10.3390/biomedicines9060687 · Cited by 100 · see citing works
Zhao, P., & Saltiel, A. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011356 · Cited by 101 · see citing works
Chen, J., Zheng, D.-X., Yu, X.-J., Sun, H.-W., Xu, Y.-T., Zhang, Y., & Xu, J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1652540 · Cited by 93 · see citing works
Self-citationXie, C., Ge, M., Jin, J., Xu, H., Mao, L., Geng, S., Wu, J., Zhu, J., Li, X., & Zhong, C. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.122549 · Cited by 91 · see citing works
The NADPH Oxidase Family and Its Inhibitors
Chocry, M., & Leloup, L. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7915 · Cited by 89 · see citing works
Hao, Y., Song, K., Tan, X., Ren, L., Guo, X., Zhou, C., Li, H., Wen, J., Meng, Y., Lin, M., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c07796 · Cited by 92 · see citing works
Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities
Wang, M., Xiao, Y.-P., Miao, J., Zhang, X., Liu, M., Zhu, L., Liu, H., Shen, X., Wang, J.-H., Xie, B., et al. (2025) · Antioxidants · doi:10.3390/antiox14060735 · Cited by 102 · see citing works
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U. G., & Schmidt, H. H. H. W. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.038 · Cited by 77 · see citing works
Inhibiting the Activity of NADPH Oxidase in Cancer
Konaté, M. M., Antony, S., & Doroshow, J. H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8046 · Cited by 77 · see citing works
Duan, J., Gao, S., Tu, S., Lenahan, C., Shao, A., & Sheng, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6631805 · Cited by 76 · see citing works
Yang, W., Yang, S., Zhang, F., Cheng, F., Wang, X., & Rao, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.11 · Cited by 69 · see citing works
Lin, X.-T., Yu, H.-Q., Fang, L., Tan, Y., Liu, Z.-Y., Wu, D., Zhang, J., Xiong, H.-J., & Xie, C. (2021) · eLife · doi:10.7554/elife.70715 · Cited by 67 · see citing works
The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer
Zeng, W., Long, X., Liu, P., & Xie, X. (2023) · International Journal of Cancer · doi:10.1002/ijc.34486 · Cited by 69 · see citing works
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
Binatti, E., Gerussi, A., Barisani, D., & Invernizzi, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126649 · Cited by 62 · see citing works
Zhang, X. K., Cheng, C., Zhang, G., Xiao, M., Li, L., Wu, S., & Lu, X. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112453 · Cited by 50 · see citing works
Novel Therapeutic Approaches to Liver Fibrosis Based on Targeting Oxidative Stress
Blas‐García, A., & Apostolova, N. (2023) · Antioxidants · doi:10.3390/antiox12081567 · Cited by 45 · see citing works
Nascè, A., Gariani, K., Jornayvaz, F. R., & Szántó, I. (2022) · Antioxidants · doi:10.3390/antiox11061131 · Cited by 47 · see citing works
Weng, J., Liu, S., Zhou, Q., Xu, W., Xu, M., Gao, D., Shen, Y., Yi, Y., Shi, Y. Y., Dong, Q., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006655 · Cited by 42 · see citing works
Matthews, D., Li, H., Zhou, J., Li, Q., Glaser, S. S., Francis, H., Alpini, G. D., & Wu, C. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.06.010 · Cited by 38 · see citing works
Li, W., Zhou, X., Xu, S., Cao, N., Li, B., Chen, W., Yang, B., Yuan, M., & Xu, D. (2022) · Poultry Science · doi:10.1016/j.psj.2022.101725 · Cited by 37 · see citing works
The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Cell Biology in Health and Disease
Herranz‐Itúrbide, M., Peñuelas‐Haro, I., Espinosa‐Sotelo, R., Bertrán, E., & Fabregat, I. (2021) · Cells · doi:10.3390/cells10092312 · Cited by 35 · see citing works
Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis
Liu, W., Wang, B., Zhou, M., Liu, D., Chen, F., Zhao, X., & Lu, Y. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0272 · Cited by 35 · see citing works
Song, Y., Li, Q., Liao, S., Zhong, K., Jin, Y., & Zeng, T. (2020) · Virology · doi:10.1016/j.virol.2020.05.011 · Cited by 34 · see citing works
Tumour-associated macrophages: versatile players in the tumour microenvironment
Ji, Z. Z., Chan, M. K., Chan, A. S. W., Leung, K. T., Jiang, X., To, K., Wu, Y., & Tang, P. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1261749 · Cited by 32 · see citing works
Vandierendonck, A., Degroote, H., Vanderborght, B., Verhelst, X., Geerts, A. M., Devisscher, L., & Vlierberghe, H. V. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01837-6 · Cited by 32 · see citing works
Regulation mechanism of endoplasmic reticulum stress on metabolic enzymes in liver diseases
Zhou, S., Cheng, K., Peng, Y., Liu, Y., Hu, Q., Zeng, S., Qi, X., & Yu, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107332 · Cited by 29 · see citing works
The Hippo Signaling Pathway: The Trader of Tumor Microenvironment
Yang, D., Zhang, N., Li, M., Hong, T., Meng, W., & Ouyang, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.772134 · Cited by 29 · see citing works
Nox1 downregulators: A new class of therapeutics
Barton, M., Meyer, M. R., & Prossnitz, E. R. (2019) · Steroids · doi:10.1016/j.steroids.2019.108494 · Cited by 28 · see citing works
Anticancer effect of caudatin in diethylnitrosamine‑induced hepatocarcinogenesis in rats
Song, J., Ding, W., Liu, B., Liu, D., Xia, Z., Zhang, L., Cui, L., Luo, Y., Jia, X., & Feng, L. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11135 · Cited by 27 · see citing works
Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses
Mannan, A., Germon, Z. P., Chamberlain, J., Sillar, J. R., Nixon, B., & Dun, M. D. (2021) · Antioxidants · doi:10.3390/antiox10101616 · Cited by 25 · see citing works
Cross-Talk of NADPH Oxidases and Inflammation in Obesity
Morawietz, H., Brendel, H., Diaba‐Nuhoho, P., Catar, R. A., Perakakis, N., Wolfrum, C., & Bornstein, S. R. (2023) · Antioxidants · doi:10.3390/antiox12081589 · Cited by 29 · see citing works
Antifibrotic Effect of Selenium-Containing Nanoparticles on a Model of TAA-Induced Liver Fibrosis
Varlamova, E. G., Goltyaev, M. V., Rogachev, V. V., Gudkov, S. V., Karaduleva, E. V., & Turovsky, E. A. (2023) · Cells · doi:10.3390/cells12232723 · Cited by 26 · see citing works
Deletion of NoxO1 limits atherosclerosis development in female mice
Buchmann, G., Schürmann, C., Warwick, T., Schulz, M. H., Spaeth, M., Müller, O. J., Schröder, K., Jo, H., Weißmann, N., & Brandes, R. P. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101713 · Cited by 26 · see citing works
Diethylnitrosamine Induction of Hepatocarcinogenesis in Mice
Sotty, J., Bablon, P., Weiss, P.-H., & Soussan, P. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3694-7_2 · Cited by 21 · see citing works
Finetti, F., Schiavo, I., Ercoli, J., Zotta, A., Boda, E., Retta, S. F., & Trabalzini, L. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109527 · Cited by 21 · see citing works
Xu, L., Balzarolo, M., Robinson, E. L., Lorenz, V., Verde, G. D., Joray, L., Mochizuki, M., Kaufmann, B. A., Valstar, G., de Jager, S. C. A., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab349 · Cited by 20 · see citing works
Jiang, S., Xu, L., Chen, Y., Shu, Z., Lv, L., Zhao, Y., Bi, K., Yang, S., Wang, Q., & Li, L. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2458-1 · Cited by 19 · see citing works
Kurhe, Y., Caputo, M., Cansby, E., Xia, Y., Kumari, S., Anand, S. K., Howell, B. W., Marschall, H., & Mahlapuu, M. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.09.018 · Cited by 19 · see citing works
Shan, Z., Wu, W., Yan, X., Yang, Y. P., Luo, D., Liu, Q., Li, X., Goel, A., & Ma, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16387 · Cited by 15 · see citing works
The NADPH Oxidase Isoform 1 Contributes to Angiotensin II-Mediated DNA Damage in the Kidney
Zimnol, A., Spicker, N., Balhorn, R., Schröder, K., & Schupp, N. (2020) · Antioxidants · doi:10.3390/antiox9070586 · Cited by 16 · see citing works
Nrf2 activation contributes to hepatic tumor-augmenting effects of developmental arsenic exposure
Wu, R., Chen, X., Wu, H., Hu, Y., Wang, G., Wang, H., Yang, B., Fu, J., Gao, Y., Pi, J., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155685 · Cited by 14 · see citing works
The Metabolic Control of Myeloid Cells in the Tumor Microenvironment
Ramel, E., Lillo, S., Daher, B., Fioleau, M., Daubon, T., & Saleh, M. (2021) · Cells · doi:10.3390/cells10112960 · Cited by 15 · see citing works
Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors
Yuan, W., Xiao, C., Lao, X., Zheng, L., & Kuang, D. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03637-1 · Cited by 13 · see citing works
Yan, Q., Zheng, W., Wang, B., Ye, B., Luo, H., Yang, X., Zhang, P., & Wang, X. (2021) · BioData Mining · doi:10.1186/s13040-021-00261-y · Cited by 13 · see citing works
Gao, Y., Yuan, Y., Shu, W., Chen, Y., Zhang, Z., Feng, Y., Jiang, B., Ma, S., Hu, R., Fang, C., et al. (2023) · Oncogenesis · doi:10.1038/s41389-023-00473-3 · Cited by 12 · see citing works
Self-citationLarion, S., Padgett, C. A., MINTZ, J. D., Thompson, J. A., Butcher, J. T., de Chantemèle, E. J. B., Haigh, S. B., Khurana, S., Fulton, D. J., & Stepp, D. W. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00153.2023 · Cited by 11 · see citing works
Kim, J. Y., Kang, W., Yang, S., Park, S. H., Ha, S. Y., & Paik, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-72721-4 · Cited by 11 · see citing works
NOX1/NADPH oxidase is involved in the LPS-induced exacerbation of collagen-induced arthritis
Matsumoto, M., Liu, J., Iwata, K., Ibi, M., Asaoka, N., Zhang, X., Katsuyama, M., Matsuda, M., Nabe, T., Schröder, K., et al. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.01.009 · Cited by 10 · see citing works
Dual-regulation by Cx32 in hepatocyte to trigger and worsen liver graft injury
Huang, F., Deng, Z., Zhang, Q., Zhang, Z., Li, X., Zeng, W., Wang, Y., Hei, Z., & Yuan, D. (2023) · Translational research · doi:10.1016/j.trsl.2023.07.008 · Cited by 9 · see citing works
Lin, Y., Ku, C., Wuputra, K., Wu, D., & Yokoyama, K. K. (2024) · Cells · doi:10.3390/cells13191648 · Cited by 8 · see citing works
Tumor immune microenvironment modulation by cholesterol in hepatocellular carcinoma
Escobedo‐Calvario, A., Chávez-Rodríguez, L., Nieves, A. S., Souza-Arroyo, V., Miranda-Labra, R. U., Gómez-Quiroz, L. E., & Gutiérrez‐Ruíz, M. C. (2022) · Exploration of Digestive Diseases · doi:10.37349/edd.2022.00003 · Cited by 7 · see citing works
The role of liver macrophages in viral liver pathogenesis
Brantly, A., Yeakle, K., Bouchard, M. J., Gaskill, P. J., & Nonnemacher, M. R. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf088 · Cited by 6 · see citing works
Guo, X., Zhu, B., Xu, H., Li, H., Jiang, B., Wang, Y., Zheng, B., Glaser, S. S., Alpini, G. D., & Wu, C. (2020) · Liver Research · doi:10.1016/j.livres.2020.08.004 · Cited by 6 · see citing works
Acupuncture’s Immunomodulatory Effects on Macrophages in Allergic Disorders: A Systematic Review
Qu, Y., Gu, Y., Zhang, X., Wang, Y., & Xing, X. (2025) · Journal of Asthma and Allergy · doi:10.2147/jaa.s516732 · Cited by 5 · see citing works
Isoform-Selective Nox Inhibitors: Advances and Future Perspectives
Dustin, C. M., Cifuentes-Pagano, E., & Pagano, P. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-23752-2_21 · Cited by 5 · see citing works
Lagal, D. J., Bárcena, J. A., Requejo-Aguilar, R., Padilla, C. A., & Leto, T. L. (2023) · Advances in Redox Research · doi:10.1016/j.arres.2023.100080 · Cited by 5 · see citing works
The role and mechanism of NADPH oxidase in the development and progression of thyroid carcinoma.
Dang, H., Sheng, J., Tang, P., Peng, X., Zhang, R., Zhao, X., Hu, J., & Xu, T. (2023) · PubMed Central · Cited by 5 · see citing works
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validationPreprint
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U., & Schmidt, H. H. H. W. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/382226 · Cited by 5 · see citing works
Mu, W., Shi, Y.-G., Jian, Y.-L., Li, L., Zhou, Y., Wang, H., & Yang, G. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01623-6 · Cited by 4 · see citing works
Self-citationNADPH Oxidase 1 Mediates Endothelial Dysfunction and Hypertension in a Murine Model of Obesity
Padgett, C. A., Butcher, J. T., Larion, S., MINTZ, J. D., Fulton, D. J., & Stepp, D. W. (2026) · Antioxidants · doi:10.3390/antiox15010060 · Cited by 3 · see citing works
Guo, X., Li, H., Zhu, B., Wang, X., Xu, Q., Aquino, E., Koo, M., Li, Q., Cai, J. J., Glaser, S. S., et al. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109770 · Cited by 3 · see citing works
In vivo Study of a Newly Synthesized Chromen-4-one Derivative as an Antitumor Agent against HCC
Nabeel, A. I., Mansour, S. Z., Mahdy, E.-S. M. E., El‐mezayen, H. A., & Mohamed, S. A. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00724-9 · Cited by 3 · see citing works
Single‐Dose Toxicity Study on ML171, a Selective NOX1 Inhibitor, in Mice
Oh, S., Ahn, J., Oh, E., Kim, Y.-J., Yook, J.-M., Lim, J., Jung, H., Choi, J., Kim, C., Park, S.-H., et al. (2021) · BioMed Research International · doi:10.1155/2021/5515478 · Cited by 2 · see citing works
Role of NADPH Oxidase 4 on Dry Eye Syndrome in Mice
Guo, M., Liu, T., Miao, Y., Pan, X., & Liu, B. (2024) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2024.0002 · Cited by 2 · see citing works
Diverse immunological roles of liver‐resident immune cells in liver diseases
Fan, Z., Li, X., Jiang, P., Teng, D., & Cai, J. (2026) · Precision Medical Sciences · doi:10.1002/prm2.70026 · Cited by 1 · see citing works
Hegazy, D. H., Hazem, S. H., & El‐Kashef, D. H. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05293-x · Cited by 1 · see citing works
ROS-mediated pathways: potential role in hepatocellular carcinoma biology and therapy
Malla, R. R., Marni, R., & Chakraborty, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98807-0.00004-1 · Cited by 1 · see citing works
Hepatobiliary Cancers and Immunology
Kodama, T., & Takehara, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_31
The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Fibrosis and Cancer
Amengual, J., Espinosa‐Sotelo, R., Cantos‐Cortes, A., Gonfaus-Ortiz, G., Alay, A., Campuzano, V., Egea, G., Bertrán, E., & Fabregat, I. (2026) · Springer eBooks · doi:10.1007/978-3-032-21135-4_21
Li, M., & Mailloux, R. J. (2026) · Journal of Cellular Biochemistry · doi:10.1002/jcb.70104
Vos, Z. D., Heyerick, L., Baekelandt, A., Morren, L., Hoorens, A., Eker, H. H., de Carvalho, L. A., Gryspeerdt, F., Berrevoet, F., Stocks, H., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1808515
Marín-Díaz, B., González-Rico, F. J., Ordóñez-Mata, L., Román, Á., Merino, J. M., & Fernández‐Salguero, P. M. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00596-0
- Authors
- Liang, S., Ma, H.-Y., Zhong, Z., Dhar, D., Liu, X., Xu, J., Koyama, Y., Nishio, T., Karin, D., Karin, G., Mccubbin, R., Zhang, C., Hu, R., Yang, G., Chen, L., Ganguly, S., Lan, T., Karin, M., Kisseleva, T., & Brenner, D. A.
- Affiliations
- University of California San Diego (US)
- Kyoto University (JP)
- Shandong University (CN)
- Sun Yat-sen University (CN)
- Guangdong Pharmaceutical University (CN)
- Corresponding author
- Kisseleva, Tatiana
- Brenner, David A.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 156
- Issue
- 4
- Pages
- 1156-1172.e6
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC6409207
- OpenAlex
- W2900859474
- Cited by
- 92
- References
- 72
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 12 · 2023: 14 · 2022: 9 · 2021: 21 · 2020: 15 · 2019: 8 · 2018: 1
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gastroenterology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (R01 DK101737-01A1, U01 AA022614-01A1, R01 DK099205-01A1, P50 AA011999)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- NOX1, NOX4, hepatocellular carcinoma, hepatocarcinogenesis, hepatic macrophages, diethylnitrosamine, oxidative stress, inflammation, TNF-α, interleukin-6, STAT3 phosphorylation, hepatic stellate cells
- MeSH terms
- Alarmins, NADPH Oxidase 1, NADPH Oxidase 4, Animals, Cell Transformation, Neoplastic, Cells, Cultured, Diethylnitrosamine, Enzyme Inhibitors, Hepatitis, Carcinoma, Hepatocellular, Humans, Liver, Liver Neoplasms, Experimental, Macrophages, Male, Mice, Inbred C57BL, Necrosis, Tumor Necrosis Factor-alpha, Interleukin-6, Culture Media, Conditioned, Mice, Knockout, Hepatocytes, Tumor Burden, Cell Proliferation, STAT3 Transcription Factor, Mice, Hepatic Stellate Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review